Vikman
Active member
- Joined
- Sep 18, 2015
- Messages
- 59
- Reason
- Lost a loved one
- Diagnosis
- 09/2015
- Country
- US
- State
- CT
- City
- New London
This was on the front page of News
"CNS is pleased to report that the recently completed Nuedexta ALS treatment trial was a resounding success. The nationwide study, conducted at seven NEALS research sites, convincingly demonstrated that Nuedexta can enhance speech and swallowing in ALS patients and facilitate their ability to control their oral secretions. The results of the trial will be presented at the upcoming International ALS meeting."
Will be interesting to see the results.
"CNS is pleased to report that the recently completed Nuedexta ALS treatment trial was a resounding success. The nationwide study, conducted at seven NEALS research sites, convincingly demonstrated that Nuedexta can enhance speech and swallowing in ALS patients and facilitate their ability to control their oral secretions. The results of the trial will be presented at the upcoming International ALS meeting."
Will be interesting to see the results.